(Q33182059)

English

Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

23 July 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

5

object named as

Osterhaus AD

1 reference

Europe PubMed Central

23 July 2017

Bronno van der Holt

10

object named as

van der Holt B

1 reference

Europe PubMed Central

23 July 2017

author name string

van Esser JW

1

1 reference

Europe PubMed Central

23 July 2017

Niesters HG

2

1 reference

Europe PubMed Central

23 July 2017

Thijsen SF

3

1 reference

Europe PubMed Central

23 July 2017

Meijer E

4

1 reference

Europe PubMed Central

23 July 2017

Wolthers KC

6

1 reference

Europe PubMed Central

23 July 2017

Boucher CA

7

1 reference

Europe PubMed Central

23 July 2017

Gratama JW

8

1 reference

Europe PubMed Central

23 July 2017

Budel LM

9

1 reference

Europe PubMed Central

23 July 2017

van Loon AM

11

1 reference

Europe PubMed Central

23 July 2017

Löwenberg B

12

1 reference

Europe PubMed Central

23 July 2017

Verdonck LF

13

1 reference

Europe PubMed Central

23 July 2017

Cornelissen JJ

14

1 reference

Europe PubMed Central

23 July 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

23 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

23 July 2017

113

1 reference

Europe PubMed Central

23 July 2017

814-821

1 reference

Europe PubMed Central

23 July 2017

3

1 reference

Europe PubMed Central

23 July 2017

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Detection and quantification of cell-free Epstein-Barr virus by polymerase chain reaction and subsequent DNA enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02789.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02789.X

1 reference

Europe PubMed Central

23 July 2017

release_2zkhrduvrffipoj4i2wywrh4ja

1 reference

https://api.fatcat.wiki/v0/release/2zkhrduvrffipoj4i2wywrh4ja

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33182059&oldid=1837731242"